Case Studies

  • Orphan drug costs and utilization are a double-threat to sustainability for small and mid-market health plans. Learn how MRIoA can help health plans gain control of orphan drug costs and improve outcomes by ensuring access for patients truly in need while minimizing inappropriate utilization.
Download